Track topics on Twitter Track topics that are important to you
Change in the accounting policy - IAS 19 (revised) Employee Benefits. Presentational change - Pharmaceuticals Division geographic sales split changed to reflect new internal organisational structure. No impact on 2013 outlook as communicated at FY 2012 results: sales to grow in line with previous year, Core EPS targeted to grow ahead of sales. Roche expects to further increase dividend.NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...